# Clinical Study of the Safety and Efficacy of BAT5906 Injection

> **NCT04772105** · PHASE1,PHASE2 · COMPLETED · sponsor: **Bio-Thera Solutions** · enrollment: 60 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** 2.5mg of BAT5906
- **DRUG:** 4.0mg of BAT5906

## Key facts

- **NCT ID:** NCT04772105
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-16
- **Primary completion:** 2023-11-06
- **Final completion:** 2023-11-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04772105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04772105, "Clinical Study of the Safety and Efficacy of BAT5906 Injection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04772105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*